(Q45151192)

10 December 2017

title

Inhaled corticosteroids, bone density, and risk of fracture (English)

1 reference

10 December 2017

P N Sambrook

1

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

10 December 2017

1 reference

10 December 2017

volume

355

1 reference

10 December 2017

issue

9213

1 reference

10 December 2017

page(s)

1385

1 reference

Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902134-6

7 January 2021

Corticosteroid effects on proximal femur bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902134-6

7 January 2021

The bone density of female twins discordant for tobacco use

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902134-6

7 January 2021

Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902134-6

7 January 2021

Prediction of osteoporotic fractures by postural instability and bone density

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902134-6

7 January 2021

Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902134-6

7 January 2021

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902134-6

7 January 2021

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902134-6

7 January 2021

Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902134-6

7 January 2021

10.1016/S0140-6736(00)02134-6

Identifiers

DOI

1 reference

10 December 2017

1 reference